Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers

We are thrilled to announce our upcoming CEO Webinar Series with Apollomics: Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, featuring Dr. Guo Liang Yu, Co-Founder, Executive Director, Chairman & CEO of Apollomics Inc. 

Apollomics Inc. is a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers. The company recently announced the completion of its business combination with Maxpro Capital Acquisition Corp. Apollomics’ Class A ordinary shares and public warrants are expected to commence trading on, March 30, 2023, on the Nasdaq Capital Market under the symbols "APLM" and “APLMW,” respectively. 

Co-host: MSQ Ventures and BioAroundWorld 

Guest Speaker: Dr. Guo Liang Yu, Co-Founder, Executive Director, Chairman & CEO of Apollomics Inc. 

Moderator: Echo Hindle-Yang, President & CEO, MSQ Ventures 

Date: Wednesday, May 11th, 2023 

Time: 9pm – 10pm BJT 

          9am – 10am ET 

Register Here: https://us02web.zoom.us/webinar/register/WN_FTvI2jmdSC6RTCUOfBVGUg#/registration 

* After the webinar, attendees will have an opportunity to set up a 1-1 session with the guest speaker post-event via MSQ